| aDC | activated dendritic cell |
| Angio | Angiogenesis |
| AP | Antigen Presentation |
| B2M | Beta-2-Microglobulin |
| BAP1 | BRCA1 Associated Protein 1 |
| CALR | Calreticulin |
| CI | Confidence Interval |
| CM | Cutaneous Melanoma |
| CTLA-4 | Cytotoxic T-Lymphocyte Antigen-4 |
| D3 | Disomy of Chromosome 3 |
| DC | dendritic cell |
| DEG | Differentially Expressed Genes |
| DFS | Disease Free Survival |
| FPKM | Fragments per Kilobase per Million |
| GEO | Gene Expression Omnibus |
| GSEA | Gene Set Enrichment Analysis |
| GSVA | Gene Set Variation Analysis |
| GZMA | Granzyme A |
| HLA | Human Leukocyte Antigen |
| HR | Hazard Ratio |
| iDC | immature dendritic cell |
| IL2 | Interleukin-2 |
| IPS | Immunophenoscore |
| KM | Kaplan-Meier |
| M1 | liver metastasis |
| M1a | small lesion liver metastasis |
| M3 | Monosomy of Chromosome 3 |
| MSigDB | Molecular Signatures Database |
| mTORC1 | Mammalian target of rapamycin complex 1 |
| MUM | Metastatic Uveal Melanoma |
| NES | Normalized Enrichment Score |
| NK | Natural Killer |
| OS | Overall Survival |
| PD-1 | Programmed Cell death protein 1 |
| PDL1 | Programmed Death Ligand 1 |
| PET-TC | Positron emission tomography |
| PFS | Progression Free Survival |
| PI3K | Phosphoinositide 3-kinase |
| PRF | Perforin |
| TAP | Tapasin |
| TIL | Tumor Infiltrating Lymphocyte |
| TIS | T-cell Inflammatory Signature |
| TMB | Tumor Mutational Burden |
| TME | Tumor microenvironment |
| TNF-α | Tumor Necrosis Factor alpha |
| UM | Uveal Melanoma |
| VEGF | Vascular Endothelial Growth Factor |